Eversept Partners, LP - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,665,340
-9.3%
122,643
+117.3%
0.40%
-8.1%
Q2 2023$5,142,504
-35.8%
56,449
-63.5%
0.43%
-38.7%
Q4 2022$8,004,501
+92.1%
154,796
+22.5%
0.70%
+142.6%
Q3 2021$4,166,144
+652.6%
126,400
+879.8%
0.29%
+588.1%
Q1 2021$553,539
+153.6%
12,900
+238.1%
0.04%
+61.5%
Q4 2020$218,275
-91.1%
3,816
-95.3%
0.03%
-95.2%
Q3 2020$2,451,825
-82.2%
81,267
-80.7%
0.54%
-71.1%
Q2 2020$13,747,639
-42.9%
420,932
-53.2%
1.88%
-68.5%
Q1 2020$24,096,908
+153.5%
899,474
+189.8%
5.99%
+257.0%
Q4 2019$9,504,724
+396.2%
310,409
+290.4%
1.68%
+182.5%
Q3 2019$1,915,372
-35.6%
79,509
-32.2%
0.59%
-28.6%
Q2 2019$2,972,610
+46.1%
117,309
+12.4%
0.83%
+40.1%
Q1 2019$2,034,806
+44.3%
104,349
-2.4%
0.59%
-22.1%
Q4 2018$1,409,747
-20.9%
106,880
+6.6%
0.76%
-2.6%
Q3 2018$1,783,245
-17.6%
100,295
+1.9%
0.78%
-20.9%
Q2 2018$2,164,69098,3950.99%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders